PROFILE: Novo's Riis Recalls First Victoza Delivery, Growing Up With Science
This article was originally published in Scrip
Executive Summary
Jakob Riis is a Danish national who joined diabetes R&D giant Novo Nordisk in 1996 as a health economist. He has since risen through the company, via a series of marketing roles of increasing seniority, to take on his current position of executive vice-president of China, Pacific and marketing.
You may also be interested in...
Spring Break: Novo's US Head Resigns After Rough Winter
Novo Nordisk's executive VP and head of North American operations, Jakob Riis, has resigned from the company – a move not completely out of the blue considering recent rumors of conflict within the diabetes drug developer's US operations and a lackluster 2016 financial performance for the whole group.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.